Iron deficiency and neurotransmitter synthesis and function

There has been little work on the effects of irondeficiency on brain metabolism and function despite the fact that Fe deficiency is the most common nutritional disorder in the world (Garby, 1973; Kossner 8z Kalk, 1973). Fe is present in the brain in relatively large amounts and is particularly concentrated in the basal ganglia (Cumings, 1948, 1968; Hallgren 8z Sourander, 1958; Harrison, Netsky 8z Brown, 1968). Furthermore it’s concentration appears to be independent of the liver Fe stores (Hallgren 8z Sourander, 1958; Dallman, 1974). It has been suggested that Fe is a cofactor for tyrosine hydroxylase (EC 1.14.16.2) (Sourkes, 1972) and tryptophan hydroxylase (EC 1.13.11.11) (Ichiyama, Nakamura, Nishizuka 8z Hayashi, 1968; Lovenberg, Jequier & Sjoerdsma, 1968; Youdim, Hamon 8z Bourgoin, 1975), enzymes involved in the formation of catecholamines and 5-hydroxytryptamine (5-HT) respectively. The activity of the monoamine degradative enzyme monoamine oxidase (EC 1.4.3.4; MAO) has also been shown to be lowered in the tissues of both humans and rats with Fedeficiency anaemia (Symes, Sourkes, Youdim, Birnbaum & Gregoriadis, 1969; Voorhess, Stuart, Stockman 8z Oski, 1975; Youdim, Woods, Mitchell, GrahameSmith 8z Callender, 1975; Youdim, Grahame-Smith 8z Woods, 1976). We have now investigated the effects of Fe deficiency in rats on the activity of various monoamine-metabolizing enzymes in the brain. The functional activity of the monoamine neurotransmitter systems has also been investigated by measuring the behavioural responses of the rats to increased brain 5-HT and dopamine (DA) receptor stimulation. Preparation of Fe-dejcient rats Male Sprague-Dawley rats (Anglia Laboratory Animals, Huntingdon), initial weight 80+20 g (meanksm) were made Fe deficient by feeding on a semisynthetic diet of milk powder low in Fe (McCall, Newman, O’Brien, Valberg & Witts, 1962) and distilled water. Control rats were given tapwater and the milkpowder diet with ammonium ferrous sulphate (1.3 mg/g diet) added. The Fedeficient group were given ad lib. access to the diet while the control group had their food intake restricted to that of the Fe-deficient group. After 5 weeks the

[1]  W. Harrison,et al.  Trace elements in human brain: copper, zinc, iron, and magnesium. , 1968, Clinica chimica acta; international journal of clinical chemistry.

[2]  D. Grahame-Smith STUDIES IN VIVO ON THE RELATIONSHIP BETWEEN BRAIN TRYPTOPHAN, BRAIN 5‐HT SYNTHESIS AND HYPERACTIVITY IN RATS TREATED WITH A MONOAMINE OXIDASE INHIBITOR AND L‐TRYPTOPHAN , 1971, Journal of neurochemistry.

[3]  J. Winn,et al.  Brain , 1878, The Lancet.

[4]  A. R. Green,et al.  Effects of drugs on the processes regulating the functional activity of brain 5-hydroxytryptamine , 1976, Nature.

[5]  E. Pollitt,et al.  Iron deficiency and behavior. , 1976, The Journal of pediatrics.

[6]  H. Woods,et al.  Human platelet monoamine oxidase activity in iron-deficiency anaemia. , 1975, Clinical science and molecular medicine.

[7]  B. Hallgren,et al.  THE EFFECT OF AGE ON THE NON‐HAEMIN IRON IN THE HUMAN BRAIN , 1958, Journal of neurochemistry.

[8]  H. Tamir,et al.  SEROTONIN BINDING PROTEIN: ENHANCEMENT OF BINDING BY Fe2+ AND INHIBITION OF BINDING BY DRUGS 1 2 , 1976, Journal of neurochemistry.

[9]  V. Edgerton,et al.  Iron deficiency anemia and physical performance and activity of rats. , 1972, The Journal of nutrition.

[10]  P. Dallman,et al.  Brain Iron: Persistent Deficiency following Short‐term Iron Deprivation in the Young Rat , 1975, British journal of haematology.

[11]  J. Cumings The copper and iron content of brain and liver in the normal and in hepato-lenticular degeneration. , 1948, Brain : a journal of neurology.

[12]  M. Hamon,et al.  PROPERTIES OF PARTIALLY PURIFIED PIG BRAIN STEM TRYPTOPHAN HYDROXYLASE , 1975, Journal of neurochemistry.

[13]  Y. Nishizuka,et al.  Tryptophan-5-hydroxylase in mammalian brain. , 1968, Advances in pharmacology.

[14]  W. Lovenberg,et al.  Tryptophan hydroxylation in mammalian systems. , 1968, Advances in pharmacology.

[15]  D. Bower,et al.  Demonstration of Paneth cell granules using Naphthalene Black. , 1968, Journal of clinical pathology.

[16]  M. Worwood,et al.  Iron in biochemistry and medicine. , 1974 .

[17]  J. O'brien,et al.  Studies in iron metabolism , 1962, British Journal of Nutrition.

[18]  J. Stockman,et al.  Iron deficiency anemia and increased urinary norepinephrine excretion. , 1975, The Journal of pediatrics.

[19]  S. Shade Iron in Biochemistry and Medicine , 1975 .

[20]  P. Kelly,et al.  EVIDENCE CONCERNING THE INVOLVEMENT OF 5‐HYDROXYTRYPTAMINE IN THE LOCOMOTOR ACTIVITY PRODUCED BY AMPHETAMINE OR TRANYLCYPROMINE PLUS l‐DOPA , 1976, British journal of pharmacology.

[21]  H. Woods,et al.  Some properties of human platelet monoamine oxidase in iron-deficiency anaemia. , 1976, Clinical science and molecular medicine.

[22]  A. Jacobs,et al.  Activity Pattern of Iron-Deficient Rats , 1972, British medical journal.

[23]  H. Birnbaum,et al.  Decreased monoamine oxidase activity in liver of iron-deficient rats. , 1969, Canadian journal of biochemistry.

[24]  J. O'brien,et al.  Studies in iron metabolism , 1962, British Journal of Nutrition.